ReviewThoracic cancer2025

Immune Checkpoint Inhibitor-Based Therapy as the First-Line Treatment for Advanced Non-Small Cell Lung Cancer: Efficacy, Challenges, and Future Perspectives.

Xingxiang Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.